Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-08 @ 7:33 AM
Study NCT ID:
NCT05271292
Status:
RECRUITING
Last Update Posted:
2024-07-16
First Post:
2022-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Sponsor:
Chipscreen Biosciences, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAR107
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None